STOCK TITAN

Molecular Templates to Participate in Two May Virtual Investor Conferences

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

Rhea-AI Summary

Molecular Templates, Inc. (Nasdaq: MTEM) announced participation in two upcoming virtual healthcare conferences. The Bank of America Securities Virtual Healthcare Conference is scheduled for May 14, while the UBS Virtual Healthcare Conference will follow on May 18 at 9:10 AM Eastern Time. Molecular Templates focuses on developing engineered toxin bodies (ETBs), offering innovative therapies against cancer and serious diseases. Further details and webcast links are available in the press announcement.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction – MTEM

-1.80%
1 alert
-1.80% News Effect

On the day this news was published, MTEM declined 1.80%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

AUSTIN, Texas, May 13, 2020 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates” or “MTEM”), a clinical-stage biopharmaceutical company focused on the discovery and development of the company’s proprietary engineered toxin bodies (ETBs), which are differentiated, targeted, biologic therapeutics for cancer and other serious diseases, today announced that management will participate in the Bank of America Securities Virtual Healthcare Conference and the UBS Virtual Healthcare Conference.

Bank of America Securities Virtual Healthcare Conference
Date: May 14
   
UBS Virtual Healthcare Conference
Date: May 18
Presentation Time: 9:10am Eastern Time
Webcast: Click here for webcast
   

About Molecular Templates 
Molecular Templates is a clinical-stage company focused on the discovery and development of targeted biologic therapeutics. Molecular Templates’ proprietary drug platform technology, known as engineered toxin bodies, or ETBs, leverages the resident biology of a genetically engineered form of Shiga-like Toxin A subunit to create novel therapies with potent and differentiated mechanisms of action for cancer and other serious diseases.

Investor Contact:

Adam Cutler
Chief Financial Officer
adam.cutler@mtem.com
862-204-4006

Source: Molecular Templates, Inc.

FAQ

When is the Bank of America Securities Virtual Healthcare Conference for MTEM?

The Bank of America Securities Virtual Healthcare Conference for Molecular Templates is on May 14.

What time is the UBS Virtual Healthcare Conference presentation for MTEM?

The UBS Virtual Healthcare Conference presentation for Molecular Templates is scheduled for 9:10 AM Eastern Time on May 18.

What is the focus of Molecular Templates' drug platform technology?

Molecular Templates' drug platform technology focuses on engineered toxin bodies (ETBs) for targeted biologic therapeutics.

What type of company is Molecular Templates?

Molecular Templates is a clinical-stage biopharmaceutical company specializing in cancer therapeutics.
Molecular Templates Inc

OTC:MTEM

View MTEM Stock Overview

MTEM Rankings

MTEM Latest News

MTEM Stock Data

191.92k
6.32M
Pharmaceutical Preparation Manufacturing
Pharmaceutical Preparations
Link
US
AUSTIN